Document ID: chunk:federal_register_of_legislation:F2024N01179:front:0:p1
Version: federal_register_of_legislation:F2024N01179
Segment Type: other
Provision Reference: 
Character Range: 0–3004

PB 148 of 2024
National Health (April 2025 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2024
National Health Act 1953

I, Eden Simon, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated    19     December 2024

EDEN SIMON
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Health Resourcing Group
Department of Health and Aged Care

      1    Name

        (1)   This instrument is the National Health (April 2025 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2024.

        (2)   This instrument may also be cited as PB 148 of 2024.

      2             Commencement

          (1)        Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1                          Column 2        Column 3
Provisions                        Commencement    Date/Details
1.  The whole of this instrument  1 January 2025

               Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

          (2)          Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

      3             Definition

                       Note: A number of expressions used in this instrument are defined in Part VII the Act.

      In this instrument:

         Act means the National Health Act 1953.

       reduction day in this instrument refers to 1 April 2025.

      4             Authority

      This instrument is made under subsection 99ACF(3) of the Act.

      5 Brand of pharmaceutical item not subject to a price reduction

  I determine, under paragraph 99ACF(3)(a) of the Act, that the approved ex-manufacturer price, and each of the claimed prices (if applicable) of each brand of pharmaceutical item specified in column 2 as an item in the table in Schedule 1 is not reduced under a provision mentioned in item 2A or item 3A or item 4A of the table in subsection 99ACF(1) of the Act, as appropriate, in relation to the reduction day.
6 Brand of pharmaceutical item subject to a lower price reduction than would otherwise apply

    I determine, under paragraph 99ACF(3)(b) of the Act, that the approved ex-manufacturer price, and each of the claimed prices (if applicable) of a brand of pharmaceutical item specified in column 2 of an item in the table in Schedule 2 is reduced under a provision mentioned in items 2A or 4A of the table in subsection 99ACF(1) of the Act, as appropriate, in relation to the reduction day by the percentage specified in column 3 of the